{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:35:34Z","timestamp":1768325734711,"version":"3.49.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T00:00:00Z","timestamp":1557360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The incidence of chronic kidney disease (CKD) is 10 times higher in human immunodeficiency virus (HIV)-infected patients than in the general population. We explored the prevalence and determinants of proximal tubular dysfunction (PTD) in HIV-infected individuals, and assessed the impact of the tubulopathy on the estimated glomerular filtration rate (eGFR) outcome.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A cohort study was performed on 694 outpatients followed in a French centre to analyse the prevalence of PTD, the diagnosis performance of screening tools and the associated factors. eGFR was prospectively evaluated to analyse the predictive value of the tubulopathy on eGFR decrease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>At inclusion, 14% of the patients presented with PTD and 5% with CKD. No individual tubular marker, including non-glomerular proteinuria, glycosuria dipstick or hypophosphataemia, registered sufficient performance to identify PTD. We found a significant interaction between tenofovir disoproxil fumarate exposure and ethnicity (P\u2009=\u20090.03) for tubulopathy risk. Tenofovir disoproxil fumarate exposure was associated with PTD in non-Africans [adjusted odds ratio (aOR)\u2009=\u20094.71, P\u2009&amp;lt;\u200910\u22123], but not in patients of sub-Saharan African origin (aOR\u2009=\u20091.17, P\u2009=\u20090.73). Among the 601 patients followed during a median of 4.3\u2009years, 13% experienced an accelerated eGFR decline. Unlike microalbuminuria and glomerular proteinuria, tubulopathy was not associated with accelerated eGFR decline.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PTD is not rare in HIV-infected individuals but is less frequent in sub-Saharan African patients and is associated with tenofovir disoproxil fumarate exposure only in non-Africans. Its diagnosis requires multiple biochemical testing and it is not associated with an accelerated eGFR decline.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfz081","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T19:15:45Z","timestamp":1555960545000},"page":"607-615","source":"Crossref","is-referenced-by-count":8,"title":["Prevalence of tubulopathy and association with renal function loss in HIV-infected patients"],"prefix":"10.1093","volume":"35","author":[{"given":"Fran\u00e7ois-Xavier","family":"Lescure","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, Bichat Hospital, AP-HP, Paris, France"},{"name":"Department of Infectious and Tropical Diseases, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm, IAME, UMRS 1137, Paris, France"},{"name":"Paris Diderot University, Sorbonne Paris Cit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Fellahi","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Hormonology, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm UMR, Centre de Recherche Saint-Antoine, UMRS 938, Paris, France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne University, UPMC, Paris, France"},{"name":"Sorbonne Universit\u00e9s, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pialoux","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm, IAME, UMRS 1137, Paris, France"},{"name":"Paris Diderot University, Sorbonne Paris Cit\u00e9, Paris, France"},{"name":"Department of Biochemistry and Hormonology, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm UMR, Centre de Recherche Saint-Antoine, UMRS 938, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Bastard","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Hormonology, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm UMR, Centre de Recherche Saint-Antoine, UMRS 938, Paris, France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne University, UPMC, Paris, France"},{"name":"Sorbonne Universit\u00e9s, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Line","family":"Eme","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, Bichat Hospital, AP-HP, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Esteve","sequence":"first","affiliation":[{"name":"Department of Nephrology and Dialysis, Tenon Hospital, AP-HP, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Gis\u00e8le","family":"Lebrette","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, Tenon Hospital, AP-HP, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Guiard-Schmid","sequence":"first","affiliation":[{"name":"Department of Infectious and Tropical Diseases, Tenon Hospital, AP-HP, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Capeau","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Hormonology, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm UMR, Centre de Recherche Saint-Antoine, UMRS 938, Paris, France"},{"name":"Institute of Cardiometabolism and Nutrition (ICAN), Sorbonne University, UPMC, Paris, France"},{"name":"Sorbonne Universit\u00e9s, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Ronco","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9s, Paris, France"},{"name":"Department of Nephrology and Dialysis, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm, UMRS 1155, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Costagliola","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9s, Paris, France"},{"name":"INSERM, Institut Pierre Louis d'\u00e9pid\u00e9miologie et de Sant\u00e9 Publique, IPLESP, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Plaisier","sequence":"first","affiliation":[{"name":"Sorbonne Universit\u00e9s, Paris, France"},{"name":"Department of Nephrology and Dialysis, Tenon Hospital, AP-HP, Paris, France"},{"name":"Inserm, UMRS 1155, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,5,9]]},"reference":[{"key":"2020040803555807000_gfz081-B1","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","article-title":"Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients","volume":"24","author":"Mocroft","year":"2010","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/ng.226","article-title":"MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis","volume":"40","author":"Kopp","year":"2008","journal-title":"Nat Genet"},{"key":"2020040803555807000_gfz081-B3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV Cohort Study","volume":"59","author":"Schouten","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020040803555807000_gfz081-B4","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2215\/CJN.00300106","article-title":"Chronic nephropathies of cocaine and heroin abuse: a critical review","volume":"1","author":"Jaffe","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020040803555807000_gfz081-B5","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3851\/IMP2761","article-title":"Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration","volume":"19","author":"Ezinga","year":"2014","journal-title":"Antivir Ther"},{"key":"2020040803555807000_gfz081-B6","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1093\/cid\/ciu617","article-title":"Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"59","author":"Lucas","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020040803555807000_gfz081-B7","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/clinchem\/42.8.1214","article-title":"Development and evaluation of a urine protein expert system","volume":"42","author":"Ivandi\u0107","year":"1996","journal-title":"Clin Chem"},{"key":"2020040803555807000_gfz081-B8","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","article-title":"Refining clinical diagnosis with likelihood ratios","volume":"365","author":"Grimes","year":"2005","journal-title":"Lancet"},{"key":"2020040803555807000_gfz081-B9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0004-9514(14)60228-2","article-title":"The interpretation of diagnostic test: a primer for physiotherapists","volume":"48","author":"Davidson","year":"2002","journal-title":"Aust J Physiother"},{"key":"2020040803555807000_gfz081-B10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/QAI.0000000000001302","article-title":"Longitudinal assessment of proximal tubular dysfunction in HIV seropositive and seronegative persons: correlates and implications","volume":"75","author":"Sheets","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020040803555807000_gfz081-B11","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1086\/598507","article-title":"Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study","volume":"48","author":"Rodr\u00edguez-N\u00f3voa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020040803555807000_gfz081-B12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.2011.124","article-title":"Increased risk of abnormal proximal renal tubular function with HIV infection and antiretroviral therapy","volume":"80","author":"Dauchy","year":"2011","journal-title":"Kidney Int"},{"key":"2020040803555807000_gfz081-B13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0009-8981(00)00252-7","article-title":"Interpreting complex urinary patterns with MDI LABLINK: a statistical evaluation","volume":"297","author":"Regeniter","year":"2000","journal-title":"Clin Chim Acta"},{"key":"2020040803555807000_gfz081-B15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2215\/CJN.03220314","article-title":"Association of urine \u03b11-microglobulin with kidney function decline and mortality in HIV-infected women","volume":"10","author":"Jotwani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2020040803555807000_gfz081-B16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/QAI.0b013e3181dd911e","article-title":"Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir\/lamivudine versus tenofovir\/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study","volume":"55","author":"Post","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020040803555807000_gfz081-B17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1471-2369-13-85","article-title":"Total protein, albumin and low-molecular-weight protein excretion in HIV-positive patients","volume":"13","author":"Campbell","year":"2012","journal-title":"BMC Nephrol"},{"key":"2020040803555807000_gfz081-B18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1097\/QAD.0000000000000760","article-title":"Effects of renal tubular dysfunction on bone in tenofovir-exposed HIV-positive patients","volume":"29","author":"Hamzah","year":"2015","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B19","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/ki.2008.326","article-title":"Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell","volume":"74","author":"Wools-Kaloustian","year":"2008","journal-title":"Kidney Int"},{"key":"2020040803555807000_gfz081-B20","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/QAD.0b013e328348a4b1","article-title":"Renal dysfunction among HIV-infected patients starting antiretroviral therapy","volume":"25","author":"Msango","year":"2011","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B21","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/cid\/ciu117","article-title":"Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia","volume":"58","author":"Mulenga","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020040803555807000_gfz081-B22","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2020040803555807000_gfz081-B23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.5527\/wjn.v4.i2.295","article-title":"African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era","volume":"4","author":"Kasembeli","year":"2015","journal-title":"World J Nephrol"},{"key":"2020040803555807000_gfz081-B24","doi-asserted-by":"crossref","first-page":"e17609","DOI":"10.1371\/journal.pone.0017609","article-title":"Renal safety of a tenofovir-containing first line regimen: experience from an antiretroviral cohort in rural Lesotho","volume":"6","author":"Bygrave","year":"2011","journal-title":"PLoS ONE"},{"key":"2020040803555807000_gfz081-B25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3851\/IMP2675","article-title":"Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial","volume":"19","author":"Landman","year":"2013","journal-title":"Antivir Ther"},{"key":"2020040803555807000_gfz081-B26","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/QAD.0b013e32834bba87","article-title":"Persistent decline in estimated but not measured glomerular filtration rate on tenofovir may reflect tubular rather than glomerular toxicity","volume":"25","author":"Vrouenraets","year":"2011","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/1528433614Z.0000000010","article-title":"Differential skeletal impact of tenofovir disoproxil fumarate in young versus old HIV-infected adults","volume":"16","author":"Grant","year":"2015","journal-title":"HIV Clin Trials"},{"key":"2020040803555807000_gfz081-B28","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/S0140-6736(15)60616-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials","volume":"385","author":"Sax","year":"2015","journal-title":"Lancet"},{"key":"2020040803555807000_gfz081-B29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.kint.2015.11.014","article-title":"Will a new tenofovir prodrug for the treatment of HIV reduce the risk of nephrotoxicity?","volume":"89","author":"Wyatt","year":"2016","journal-title":"Kidney Int"},{"key":"2020040803555807000_gfz081-B30","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1093\/ndt\/gfn236","article-title":"Microalbuminuria associated with indicators of inflammatory activity in an HIV-positive population","volume":"23","author":"Baekken","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2020040803555807000_gfz081-B31","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/QAD.0b013e3280d3587f","article-title":"Microalbuminuria in HIV infection","volume":"21","author":"Szczech","year":"2007","journal-title":"AIDS"},{"key":"2020040803555807000_gfz081-B32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000350384","article-title":"Microalbuminuria in HIV disease","volume":"37","author":"Hadigan","year":"2013","journal-title":"Am J Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/4\/607\/33016644\/gfz081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/35\/4\/607\/33016644\/gfz081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T07:57:00Z","timestamp":1586332620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/35\/4\/607\/5487288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,9]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,5,9]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz081","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2019,5,9]]}}}